|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/355 | |
| A61P 3/00 | |||
| A61P 25/28 |
| (11) | Number of the document | 2471530 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12162555.2 |
| Date of filing the European patent application | 2006-06-01 | |
| (97) | Date of publication of the European application | 2012-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 686826 P | 2005-06-01 | US | |
| 701815 P | 2005-07-21 | US | |
| 776028 P | 2006-02-22 | US |
| (72) |
Miller, Guy M.,, US
Hecht, Sidney M.,, US
|
| (73) |
Edison Pharmaceuticals, Inc.,
350 North Bernardo Avenue, Mountain View, CA 94043,
US
|
| (54) | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |
| REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |